ARTICLES BY THIS AUTHOR
- 4/5/2020
Lupin launches generic Myfortic
Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February. - 4/5/2020
Lundbeck launches Vyepti
Vyepti is the first and only intravenous treatment for migraine prevention. - 4/5/2020
CVS Health opens testing sites in 2 states, pop-up pharmacy in New Orleans
CVS Health's rapid COVID-19 drive-through testing sites in Georgia, and Rhode Island will provide on the spot test results, while its pop-up pharmacy in New Orleans will provide maintenance medication and counseling for certain COVID-19 patients. - 4/5/2020
Hy-Vee creates one-way aisle signage, suggests 1 person per cart
Hy-Vee is adding one-way directional aisle signage to maintain six feet of social distancing. - 4/5/2020
NACDS praises new Indiana law as boon for access to pharmacy services
A new Indiana law allows a pharmacist to substitute a therapeutic alternative for epinephrine products. - 4/2/2020
Elite, Lannett launch generic Adderall XR
Adderall XR, including generic versions, have a market value of approximately $1.3 billion for the 12 months ending January 2020, according to IQVIA. - 4/2/2020
Survey: Voters support measures to increase pharmacy's impact
According to a survey commissioned by NACDS, 86% of voters say pharmacists should be allowed to provide tests for COVID-19, and the same number say pharmacists should be able to administer a vaccine once developed. - 4/2/2020
Bartell Drugs outlines expanded safety measures
Bartell's is taking additional safety measures to protect employees and customers during the COVID-19 pandemic. - 4/2/2020
Cumberland to expand availability of Caldolor to treat high fevers associated with COVID-19
Cumberland's Caldolor is the only injectable NSAID that is FDA approved to treat fever. - 4/2/2020
Kinney Drugs, Clayton Distillery to supply 6,000 hand sanitizers to stores
Kinney Drugs will have Clayton Distillery's liquid hand sanitizer in all stores by April 6.